Epigenetics Market on target to reach $1,321 Million Value by 2023, Worldwide

Epigenetics is a study of the genetic changes in gene expression (active versus inactive genes) that do not involve changes in the baseline DNA sequence (phenotypic changes that do not change the genotype), affecting how cells read genes. Subsequent sexual change is a regular and natural phenomenon, but it can also be affected by factors such as age, environment / lifestyle, and disease status.

According to the report, the global epigenetics market garnered $555 million in 2016, and is expected to reach $1,321 million by 2023, registering a CAGR of 13.1% from 2017 to 2023. The report offers a detailed analysis of changing market dynamics, key market players, major segments, and competitive landscape.

Download Sample @ https://www.alliedmarketresearch.com/request-sample/846

The research provides a detailed analysis of drivers, restraints, and opportunities of the global epigenetics market. Surge in cancer prevalence, increase in funding & aids for R&D activities, and rise in collaboration between academic, pharmaceutical, and biotechnology companies drive the growth in the market. Moreover, widening applications of epigenetics in non-oncology diseases supplement the growth. However, high initial cost of instruments and scarcity of trained professionals limit the growth of this market. Moreover, untapped potential in emerging economies offer lucrative opportunities in the market.

The report offers a detailed analysis of key segments of the global epigenetics market based on product, application, end user, and geography. According to the report, the DNA-modifying enzymes segment garnered the highest revenue in the market in 2017. Moreover, the kits & assays product segment accounted for the highest share in epigenetics product market, owing to their utilization and need during the protocol and other pre-requisite steps required for DNA analysis. The next-generation sequencers segment experienced the highest growth rate, and contributed to more than half of the total market share in 2017, and is expected to maintain its dominance throughout the forecast period. This is due to increase in usage of the technology for the epigenetic investigations to achieve expected objectives. Currently, the oncology segment dominates the market in terms of revenue and is estimated to register a CAGR of 12.8% during the forecast period.

Geographically, the report analyzes the market into North America, Asia-Pacific, Europe, and LAMEA. The Asia-Pacific market is expected to experience the highest growth during the forecast period, owing to the increase in epigenetic drug discovery, rise in prevalence of cancer, and technological advancements in epigenetics research. The untapped potential of emerging economies including China and India would offer opportunities for market expansion.

The major companies analyzed in the research include Abcam plc., QIAGEN N.V., Illumina, New England Biolabs, Inc., Merck & Co., Thermo Fisher Scientific, Inc., Sigma-Aldrich Corporation, Active Motif. Diagenode, Inc., and Zymo Research Corporation.

Key Findings of the Epigenetics Market:

• The kit & assays product segment is expected to register the highest CAGR during the forecast period, 2017–2023.
• Based on applications, the oncology segment would register the highest growth rate during the forecast period.
• The academic & government research institutes segment garnered the highest revenue in 2017 and is expected to maintain its dominant share in the future.
• North America contributed the highest market share in the global epigenetics market and is estimated to grow at a CAGR of 12.3% during the forecast period. However, Asia-Pacific would experience the highest growth rate from 2017 to 2023.

More Info @ https://www.medgadget.com/2019/02/new-study-says-epigenetics-market-targets-1321-million-value-by-2023.html

About us

Allied Market Research, a market research and advisory company of Allied Analytics LLP,
provides business insights and market research reports to large as well as small &
medium enterprises. The company assists its clients to strategize business policies and
achieve sustainable growth in their respective market domain.

Allied Market Research provides one stop solution from the beginning of data collection
to investment advice. The analysts at Allied Market Research dig out factors that help
clients to understand the significance and impact of market dynamics. The company
amplies client’s insight on the factors, such as strategies, future estimations, growth
or fall forecasting, opportunity analysis, and consumer surveys among others. As
follows, the company offers consistent business intelligent support to aid the clients
to turn into prominent business firm.

Contact:

David Correa
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
Toll Free: +1-800-792-5285
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1(855)550-5975
help@alliedmarketresearch.com
Web: www.alliedmarketresearch.com

This release was published on openPR.